Policies & Disclaimers  |  Contact Us  |  Site Map  |  Important Safety Information   
Inhaled Ventavis® (iloprost) Inhalation Solution Breathe In Your Second Chance For Patients with Pulmonary Arterial Hypertension with NYHA Class III or IV Symptoms
Start and Stay on Therapy
Ventavis Patient Stories
I-neb AAD Learning Center
PAH Learning Center
PAH Pathways - Actelion Services & Support

Start and Stay on Therapy

What is Ventavis?

Ventavis is a man-made form of prostacyclin.1 Prostacyclin is a chemical that occurs naturally in your body. When there is enough prostacyclin, it helps keep arteries in the lungs open. In patients with PAH, there is too little prostacyclin. The man-made form (Ventavis) can be used to replace some of the natural prostacyclin that is missing in patients with PAH. Ventavis is approved for the treatment of NYHA Class III or IV pulmonary arterial hypertension (PAH).

How is Ventavis taken?

Ventavis is inhaled through a special device called the I-neb AAD System, which is compact, portable, and lightweight—so you can take your medication almost anywhere at any time. Inhaling Ventavis helps it get right to the lungs—the site of disease.1

How can Ventavis help?

The benefits of Ventavis therapy*†:

  • Ventavis is the only inhaled PAH therapy that can be given alone to help patients improve their PAH symptoms and walk farther. It can also be safely used with many other drugs.
  • Patients felt better doing ordinary physical activities and improved their NYHA Functional Class.1
  • Patients were able to walk farther in a timed test.1
  • Ventavis decreased the worsening of PAH symptoms.1

Read about:




ACTELION